London, United Kingdom

Christoph Christopher Lees

This inventor holds 1 USPTO granted patent. Top assignee: Schwarz Pharma Ag. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christoph Christopher Lees. Retrieved from https://idiyas.com/inventor/christoph-christopher-lees

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christoph Christopher Lees: Innovator in Transdermal Drug Delivery

Introduction

Christoph Christopher Lees is a notable inventor based in London, GB. He has made significant contributions to the field of pharmaceuticals, particularly in drug delivery systems. His innovative approach has led to the development of a unique patent that addresses important medical needs.

Latest Patents

Christoph holds a patent for the "Transdermal presentation of nitroglycerin for preventing undesired labor." This invention represents a breakthrough in the administration of medication, allowing for effective delivery through the skin, which can enhance patient compliance and therapeutic outcomes. He has 1 patent to his name.

Career Highlights

Christoph is currently employed at Schwarz Pharma AG, a company known for its commitment to developing innovative pharmaceutical solutions. His work at Schwarz Pharma AG has allowed him to focus on advancing drug delivery technologies that can improve patient care.

Collaborations

Throughout his career, Christoph has collaborated with esteemed colleagues, including Bruce Ramsay and John Francis Martin. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions in the pharmaceutical industry.

Conclusion

Christoph Christopher Lees is a distinguished inventor whose work in transdermal drug delivery has the potential to transform patient treatment options. His contributions to the field highlight the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…